Intellia Therapeutics Inc (NTLA)
Statistics
Key valuation multiples, financial performance ratios, profitability metrics, and per share data consolidated into a single structured view. Each metric is benchmarked against both industry and sector averages — providing immediate context on whether the company is trading at a premium or discount relative to its direct peers and the broader market segment.
Valuation & Market Metrics
Market Capitalization
$1.70B
EV to revenue ratio (TTM)
27.53
EV to ebitda
-5.51
Financial Performance
Revenue (TTM)
$0.05B
Gross profit (TTM)
-$0.22B
EBITDA
-$0.43B
Profitability
Operating margin (TTM)
-1,708.00%
Profit margin
<0.01%
Return on assets (TTM)
-29.90%
Return on equity (TTM)
-62.60%
Per Share Metrics
Revenue per share (TTM)
$0.42
EPS
-$3.35
Diluted EPS (TTM)
-$3.35
Book value
$4.37
Dividend per share
n/a
Dividend yield
n/a
Valuation Multiples
P/E ratio
n/a
Trailing P/E
n/a
Forward P/E
n/a
PEG ratio
-0.10
Price to sales ratio (TTM)
32.14
Price to book ratio (TTM)
2.77
Growth
Quarterly earnings growth (YoY)
-48.00%
Quarterly revenue growth (YoY)
<0.01%
Analyst Sentiment
Strong buy
1
Buy
9
Hold
6
Sell
2
Strong sell
2
Risk & Volatility
Beta
1.82